ProfileGDS4718 / 214212_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 41% 44% 90% 39% 40% 35% 45% 46% 42% 40% 41% 40% 26% 36% 35% 55% 43% 43% 32% 47% 41% 41% 42% 42% 44% 41% 46% 28% 37% 21% 30% 63% 44% 42% 50% 53% 26% 46% 42% 90% 44% 35% 58% 38% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.0584441
GSM549102patient 115, normal, homogenized [OPG study]5.2373244
GSM549104patient 119, normal, homogenized [OPG study]9.2854590
GSM549108patient 138, normal, homogenized [OPG study]4.9952639
GSM549119patient 077, normal, homogenized [OPG study]5.0176140
GSM549133patient 032, cancer, homogenized [OPG study]4.6825835
GSM549139patient 042, cancer, homogenized [OPG study]5.2344445
GSM549099patient 107, normal, homogenized [OPG study]5.322746
GSM549109patient 139, normal, homogenized [OPG study]5.1307142
GSM549110patient 046, normal, homogenized [OPG study]5.0042540
GSM549114patient 063, normal, homogenized [OPG study]5.0010441
GSM549122patient 082, normal, homogenized [OPG study]5.0135640
GSM549134patient 033, cancer, homogenized [OPG study]4.3796726
GSM549136patient 036, cancer, homogenized [OPG study]4.732736
GSM549140patient 044, cancer, homogenized [OPG study]4.7117635
GSM549111patient 047, normal, homogenized [OPG study]5.7917255
GSM549113patient 057, normal, homogenized [OPG study]5.0743143
GSM549132patient 031, cancer, homogenized [OPG study]5.1226343
GSM549137patient 038, cancer, homogenized [OPG study]4.6219832
GSM549142patient 047, cancer, homogenized [OPG study]5.4668847
GSM549100patient 110, normal, homogenized [OPG study]5.0815841
GSM549107patient 135, normal, homogenized [OPG study]5.0012841
GSM549115patient 068, normal, homogenized [OPG study]5.0418542
GSM549116patient 072, normal, homogenized [OPG study]5.0760642
GSM549120patient 078, normal, homogenized [OPG study]5.2125944
GSM549131patient 030, cancer, homogenized [OPG study]4.9891641
GSM549118patient 074, normal, homogenized [OPG study]5.2911946
GSM549129patient 027, cancer, homogenized [OPG study]4.4847628
GSM549123patient 088, normal, homogenized [OPG study]4.8369537
GSM549124patient 006, cancer, homogenized [OPG study]4.2137321
GSM549126patient 015, cancer, homogenized [OPG study]4.536130
GSM549128patient 025, cancer, homogenized [OPG study]6.3936763
GSM549103patient 117, normal, homogenized [OPG study]5.2733444
GSM549117patient 073, normal, homogenized [OPG study]5.0754542
GSM549138patient 041, cancer, homogenized [OPG study]5.5255550
GSM549141patient 045, cancer, homogenized [OPG study]5.6431853
GSM549130patient 028, cancer, homogenized [OPG study]4.4060526
GSM549101patient 111, normal, homogenized [OPG study]5.3241846
GSM549105patient 128, normal, homogenized [OPG study]5.1018442
GSM549106patient 134, normal, homogenized [OPG study]9.3742890
GSM549112patient 048, normal, homogenized [OPG study]5.1568544
GSM549125patient 011, cancer, homogenized [OPG study]4.7578835
GSM549127patient 024, cancer, homogenized [OPG study]6.0622858
GSM549135patient 035, cancer, homogenized [OPG study]4.8545238